Human Longevity - About the company
Human Longevity is a series B company based in San Diego (United States), founded in 2013 by Peter H Diamandis and J Craig Venter. It operates as a Provider of precision medicine, preventative health assessments, and longevity care. Human Longevity has raised $377M in funding from investors like General Electric, Celgene and Emerging Technology Partners, with a current valuation of $310M.
Sectors and market segments that Human Longevity operate in
Human Longevity serves in the Life Sciences market segments.The primary business model of Human Longevity is:Company Details
Provider of precision medicine, preventative health assessments, and longevity care. The company offers comprehensive health assessments to detect life-threatening conditions early. It focuses on data-driven, personalized healthcare designed to uncover health risks. The company provides services to help individuals take control of their health.
- Website
- www.humanlongevity.com/
- Social
- Email ID
- *****@humanlongevity.com
- Phone Number
- +1 **********
- Registered Address
- San Diego, California
Key Metrics
Founded Year
2013
Location
San Diego, United States
Stage
Series B
Total Funding
$377M in 5 rounds
Latest Funding Round
Post Money Valuation
$310M as on Dec 10, 2018
Investors
Employee Count
81 as on May 31, 2026
Investment & Acquisitions
Legal entities associated with Human Longevity
Human Longevity is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Human Longevity, Inc. CIN: 463131906 , United States, Active | Dec 26, 999 | - | 83 (As on Dec 31, 2019) | - |
Human Longevity, Inc. CIN: 20151252151 , United States, Active | Apr 13, 2015 | - | - | - |
Sign up to download Human Longevity's company profile
Human Longevity's funding and investors
Human Longevity has raised a total funding of $377M over 5 rounds. Its first funding round was on Mar 04, 2014. Its latest funding round was a Series B round on Mar 13, 2023 for $39.8M. 3 investors participated in its latest round. Human Longevity has 21 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Human Longevity:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 13, 2023 | $39.8M | Series B | - | - | ||
Oct 11, 2022 | $6.92M | Series B | - | - | - | - |
Jun 14, 2019 | $30M | Series B | - | - | - |
Access funding benchmarks and valuations. Sign up today!View details of Human Longevity's funding rounds and investors
Human Longevity's founders and board of directors
Founder? Claim ProfileThe founders of Human Longevity are Peter H Diamandis and J Craig Venter. J Craig Venter is the CEO of Human Longevity.
Here are the details of Human Longevity's key team members:
- Peter H Diamandis: Co-Founder of Human Longevity and founder of 10 other companies, including Nokia Sensing XCHALLENGE, SingularityHub and Bold Capital Partners. They are also an angel investor in 6 startups.
- J Craig Venter: Co-Founder & CEO of Human Longevity.
View details of Human Longevity's Founder profiles and Board Members
Human Longevity's employee count trend
Human Longevity has 81 employees as of May 26. Here is Human Longevity's employee count trend over the years:
Uncover Human Longevity's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Human Longevity's Investments and acquisitions
Human Longevity has made 9 investments in companies including AMI Cardiac Monitoring and HUMA.AI. Human Longevity has also acquired 3 companies including DoctorsForMe.AI and LifebankUSA.Here is the list of investments & acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
2024 | Investments | 1991 | Rockville (United States) | |
Feb 03, 2022 | Investments | 2018 | Palo Alto (United States) | |
Apr 22, 2021 | Investments | 2018 | San Mateo (United States) |
_1535689687483.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by Human Longevity
Reports related to Human Longevity
Here is the latest report on Human Longevity's sector:
News related to Human Longevity
Filter this listMedia has covered Human Longevity for a total of 9 events in the last 1 year, 3 of them have been about partnerships and 2 about company updates.
•
•
Gero Secures $34M in Equity Funding to Develop Medicines for AgingTMC•Jun 17, 2026•Gero, Melnichek Investments, Human Longevity, Pfizer and 2 others
•
•
•
•
Human Longevity, Inc. Expands $1 Million Cancer Prevention Pledge for Ovarian CancerPR Newswire•Jul 18, 2025•Human Longevity
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Human Longevity
Explore our recently published companies
- Physiolab - Milton Keynes based, 2015 founded, Unfunded company
- EveyTrans - Hyderabad based, 2018 founded, Unfunded company
- anddine - London based, 2021 founded, Unfunded company
- Alaro - Noida based, 2025 founded, Unfunded company
- CTO Craft - London based, 2017 founded, Unfunded company
- Bridgetech Group - Aylesbury based, 2018 founded, Unfunded company
